Pigment epithelium-derived factor as a multifunctional antitumor factor

Area of Science:

• Oncology
• Molecular Biology
• Drug Discovery

Background:

• Cancer treatment strategies increasingly combine drugs targeting tumor cells and the tumor microenvironment.
• Antiangiogenic compounds are being developed for cancer therapy, often in combination with cytotoxic drugs.
• Pigment epithelium-derived factor (PEDF) is a natural peptide with known neurotrophic, neuroprotective, antiangiogenic, and proapoptotic activities.

Purpose of the Study:

• To review the antitumor potential of PEDF.
• To summarize recent findings on PEDF's antiangiogenic and direct antitumor effects.
• To discuss therapeutic applications of PEDF based on its mechanisms and functional domains.

Main Methods:

• Review of recent scientific literature on PEDF and cancer.
• Analysis of studies investigating PEDF's antiangiogenic properties.
• Examination of research on PEDF's direct effects on tumor cells, including differentiation and apoptosis induction.

Main Results:

• PEDF exhibits significant antiangiogenic properties, inhibiting tumor vasculature formation.
• PEDF demonstrates direct antitumor effects by inducing tumor cell differentiation and apoptosis.
• Specific functional domains of PEDF have been identified that retain therapeutic activities.

Conclusions:

• PEDF holds considerable therapeutic potential for cancer treatment due to its dual antiangiogenic and direct antitumor actions.
• Further research into PEDF's mechanisms and functional domains can guide the development of novel cancer therapies.
• PEDF represents a promising candidate for combination therapies or as a standalone agent in oncology.